bpc 157 for liver damage BPC-157 – Research Peptide bpc 157 liver damage tight

QD community oral or SC MOTS-c Daily SC, often 5 days on / 2 off AOD-9604 Daily SC Attribute Max studied dose SLU-PP-332 50 mg/kg BID (mouse, 28 days) MOTS-c 5-15 mg/kg (mouse) AOD-9604 1-5 mg/day in human Phase 2 Attribute Peak efficacy signal SLU-PP-332 ~25-30% fat-mass reduction in DIO mice over 28 days MOTS-c Improved insulin sensitivity in aged mice AOD-9604 Modest fat-loss signal in human Phase 2

In preclinical models, this translates to measurably faster healing of tendons, ligaments, muscles, and GI tissue

Park SW, He Z, Shen X et al (2012) Differential action of methamphetamine on tyrosine hydroxylase and dopamine transport in the nigrostriatal pathway of -opioid receptor knockout mice

Each time we use our Ulthera device (or Thermage or ThermiTight), our practice purchases a consumable from the manufacturer